AgeX Therapeutics and Sernova collaborate to engineer Universal Locally Immune Protected Cell Therapies
AgeX, a Juvenescence partner, and Sernova collaborate to utilize AgeX’s UniverCyteTM gene technology to generate immune-protected universal therapeutic cells for the treatment of type I diabetes and hemophilia A.